Toxicology
Abbott Toxicology > Screening Devices

Reditest™ Panel-Dip Substance Abuse Screening Device

The Reditest Panel-Dip Substance Abuse Screening Device rapidly screens for a broad range of illicit and prescription drugs. 

Reditest Panel-Dip Substance Abuse Screening Device
Benefits

Benefits

Devices are easy to use and feature a wide range of configurations for a fully customized test program. Panel-Dip devices are available in single and multi-drug configurations.

  •  1-12 configurations available for a fully customized urine testing program
  • Available drug test options include: AMP, BAR, BZO, BUP, COC, THC, MTD, mAMP, MDMA, MOP, OPI, OXY, PCP, PPX, TCA1
  • Simple procedure: collect urine, dip, and read results after five minutes
  • Administrator remains in control of test device
Helpful Documents

1. Drugs of abuse: Amphetamine (AMP1000 or AMP300), Barbiturates (BAR), Benzodiazepines (BZO), Buprenorphine (BUP), Cocaine (COC150 or COC300), Marijuana (THC), Ecstasy (MDMA) Methadone (MTD), Methamphetamine (mAMP1000 or mAMP500), Opiates (OPI300 or OPI2000), Oxycodone (OXY), Phencyclidine (PCP), Propoxyphene (PPX), and Tricyclic Antidepressants (TCA). 

For professional in-vitro diagnostic use only.

This assay provides only a preliminary analytical test result. A more specific alternate chemical method must be used in order to obtain a confirmed analytical result.

Gas chromatography-mass spectrometry (GC/MS) is the preferred confirmatory methods.

Contact Us

Leverage our comprehensive portfolio of solutions to provide the critical results you need. Contact us to discuss your organization’s drug and alcohol testing needs today.

Click Here to contact us